Cargando…
Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1
Extracellular vesicles (EVs) carrying tumor cell-derived programmed death-ligand 1 (PD-L1) interact with programmed death 1 (PD-1)-producing T cells, thus significantly lowering a patient's response to immune checkpoint blockade drugs. No drug that reinvigorates CD8+ T cells by suppressing EV P...
Autores principales: | Lee, Chan-Hyeong, Bae, Ju-Hyun, Choe, Eun-Ji, Park, Ju-Mi, Park, Seong-Sik, Cho, Hee Jin, Song, Byoung-Joon, Baek, Moon-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899590/ https://www.ncbi.nlm.nih.gov/pubmed/35265193 http://dx.doi.org/10.7150/thno.68864 |
Ejemplares similares
-
Temsirolimus Enhances Anti-Cancer Immunity by Inducing Autophagy-Mediated Degradation of the Secretion of Small Extracellular Vesicle PD-L1
por: Park, Seong-Sik, et al.
Publicado: (2022) -
Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1
por: Choe, Eun-Ji, et al.
Publicado: (2022) -
Reply to ‘Sulfisoxazole does not inhibit the secretion of small extracellular vesicles’
por: Lee, Chan-Hyeong, et al.
Publicado: (2021) -
Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A
por: Im, Eun-Ju, et al.
Publicado: (2019) -
Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury
por: Cho, Young-Eun, et al.
Publicado: (2017)